Metacrine Inc (MTCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MTCR | AZN | AMGN | GILD | BMY |
| Company | Metacrine Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.5883 | 175.49 | 363.08 | 134.02 | 57.79 |
| High | 0.5905 | 175.88 | 364.89 | 134.97 | 57.94 |
| Low | 0.5800 | 171.42 | 361.14 | 129.26 | 56.94 |
| Latest | 0.5814 | 171.61 | 363.39 | 129.83 | 57.58 |
| Change | -0.0076 | -6.88 | -0.23 | -5.01 | -0.36 |
| % Change | -1.29% | -3.85% | -0.06% | -3.72% | -0.62% |
| Volume | 83,800 | 3,596,800 | 1,632,700 | 5,935,900 | 11,203,500 |
| 20-Day Average Volume | 57,870 | 2,314,510 | 2,975,955 | 8,616,790 | 13,076,905 |
| Previous Close | 0.5890 | 178.49 | 363.62 | 134.84 | 57.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5659 | 183.33 | 356.44 | 127.77 | 56.60 |
| 20-Day Raw Stochastic | 88.35% | 0.76% | 71.21% | 50.53% | 76.10% |
| 20-Day Relative Strength | 55.86 | 40.79 | 57.57 | 49.96 | 51.85 |
| Weighted Alpha | +30.95 | +9.43 | +22.78 | +13.26 | +21.08 |
| Today's Opinion | 100% Buy | 88% Sell | 72% Buy | 56% Sell | 16% Buy |
| Previous Opinion | 100% Buy | 80% Sell | 72% Buy | 8% Sell | 16% Buy |
| Last Month's Opinion | 88% Buy | 24% Sell | 24% Buy | 40% Sell | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.00% since 06/12/23 | -12.06% since 07/02/26 | -2.88% since 07/02/26 | -1.10% since 07/02/26 | -0.95% since 07/02/26 |
| Low | 0.5502 on 06/13/23 | 171.42 on 07/10/26 | 359.47 on 07/06/26 | 127.88 on 07/06/26 | 56.49 on 07/06/26 |
| High | 0.5905 on 06/20/23 | 193.79 on 07/07/26 | 375.25 on 07/07/26 | 137.70 on 07/08/26 | 58.49 on 07/07/26 |
| 1-Month | |||||
| %Chg | +2.43% since 05/19/23 | -4.11% since 06/10/26 | +7.60% since 06/10/26 | +6.87% since 06/10/26 | +3.56% since 06/10/26 |
| Low | 0.5124 on 05/30/23 | 171.42 on 07/10/26 | 334.05 on 06/18/26 | 121.79 on 06/11/26 | 53.44 on 06/18/26 |
| High | 0.5905 on 06/20/23 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 137.70 on 07/08/26 | 58.88 on 06/30/26 |
| 3-Month | |||||
| %Chg | +2.41% since 03/20/23 | -15.89% since 04/10/26 | +3.52% since 04/10/26 | -6.59% since 04/10/26 | -1.77% since 04/10/26 |
| Low | 0.5124 on 05/30/23 | 171.42 on 07/10/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 0.5905 on 06/20/23 | 205.30 on 04/17/26 | 375.25 on 07/07/26 | 141.40 on 04/14/26 | 60.78 on 04/30/26 |
| 6-Month | |||||
| %Chg | +39.42% since 12/20/22 | -9.34% since 01/09/26 | +11.44% since 01/09/26 | +7.21% since 01/09/26 | +3.08% since 01/09/26 |
| Low | 0.3905 on 12/21/22 | 171.42 on 07/10/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.44 on 06/18/26 |
| High | 0.5905 on 06/20/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 24,750 | 266,151,328 | 196,124,496 | 161,193,024 | 117,582,448 |
| Shares Outstanding, K | 42,570 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -62,210,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -5,520,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | -0.73 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/14/22 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 06/22/23 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.28 | 16.45 | 16.11 | 9.77 |